Drug Type Small molecule drug |
Synonyms CPC 551, CPC-551, CPC551 |
Target |
Mechanism SOD1 stimulants(Superoxide dismutase stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H24ClNO3 |
InChIKeyBGEXDXBTNACMOP-UHFFFAOYSA-N |
CAS Registry627085-15-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cataract | Phase 2 | US | 11 Dec 2012 | |
dry age-related macular degeneration | Phase 2 | US | 01 Jun 2007 | |
Geographic Atrophy | Phase 2 | US | 01 Mar 2006 | |
Glycogen Storage Disease Type II | Phase 2 | US | 01 Mar 2006 | |
Epiretinal Membrane | Phase 2 | US | 01 Nov 2005 | |
Nuclear cataract | Phase 2 | US | 01 Nov 2005 | |
Retinal Perforations | Phase 2 | US | 01 Nov 2005 | |
Dry Eye Syndromes | Phase 1 | US | - | |
Glaucoma | Discovery | US | 19 Sep 2012 | |
Lacrimal gland disease | Discovery | US | 19 Sep 2012 |
Phase 2 | 10 | hqszrbwghn(bkjkuloynn) = vmigycrxus zftwfmatur (vltioziumt ) | Negative | 01 Dec 2010 | |||
Phase 2 | 137 | aqnivfmhwc(ytobxdwdzu) = bmsfrnhexf trfoxnvrwi (qhosajpwnt ) View more | Negative | 01 Apr 2010 | |||
aqnivfmhwc(ytobxdwdzu) = wznrvqkeod trfoxnvrwi (qhosajpwnt ) View more | |||||||
Phase 1/2 | 10 | onffxoiiop(boyinvopiq) = wxybqxodzl ixwhttscru (ejizkicnkm ) | Positive | 01 Apr 2010 |